COVID-19 Impact on Global Biopharmaceutical Third Party Logistics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Biopharmaceutical Third Party Logistics Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Biopharmaceutical Third Party Logistics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Transportation
  • 1.4.3 Warehousing
  • 1.4.4 Value-added Services
  • 1.4.5 Other
• 1.5 Market by Application
  • 1.5.1 Global Biopharmaceutical Third Party Logistics Market Share by Application: 2020 VS 2026
  • 1.5.2 Biopharmaceutical Manufacturers
  • 1.5.3 Biopharmaceutical Distributors
  • 1.5.4 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Biopharmaceutical Third Party Logistics Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Biopharmaceutical Third Party Logistics Industry
    • 1.6.1.1 Biopharmaceutical Third Party Logistics Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Biopharmaceutical Third Party Logistics Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Biopharmaceutical Third Party Logistics Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Biopharmaceutical Third Party Logistics Market Perspective (2015-2026)
• 2.2 Biopharmaceutical Third Party Logistics Growth Trends by Regions
  • 2.2.1 Biopharmaceutical Third Party Logistics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Biopharmaceutical Third Party Logistics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Biopharmaceutical Third Party Logistics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Biopharmaceutical Third Party Logistics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Biopharmaceutical Third Party Logistics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Biopharmaceutical Third Party Logistics Players by Market Size
  • 3.1.1 Global Top Biopharmaceutical Third Party Logistics Players by Revenue (2015-2020)
  • 3.1.2 Global Biopharmaceutical Third Party Logistics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Biopharmaceutical Third Party Logistics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Biopharmaceutical Third Party Logistics Market Concentration Ratio
  • 3.2.1 Global Biopharmaceutical Third Party Logistics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Third Party Logistics Revenue in 2019
• 3.3 Biopharmaceutical Third Party Logistics Key Players Head office and Area Served
• 3.4 Key Players Biopharmaceutical Third Party Logistics Product Solution and Service
• 3.5 Date of Enter into Biopharmaceutical Third Party Logistics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Biopharmaceutical Third Party Logistics Historic Market Size by Type (2015-2020)
• 4.2 Global Biopharmaceutical Third Party Logistics Forecasted Market Size by Type (2021-2026)

5 Biopharmaceutical Third Party Logistics Breakdown Data by Application (2015-2026)

• 5.1 Global Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)
• 5.2 Global Biopharmaceutical Third Party Logistics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Biopharmaceutical Third Party Logistics Market Size (2015-2020)
• 6.2 Biopharmaceutical Third Party Logistics Key Players in North America (2019-2020)
• 6.3 North America Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
• 6.4 North America Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Biopharmaceutical Third Party Logistics Market Size (2015-2020)
• 7.2 Biopharmaceutical Third Party Logistics Key Players in Europe (2019-2020)
• 7.3 Europe Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
• 7.4 Europe Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

8 China

• 8.1 China Biopharmaceutical Third Party Logistics Market Size (2015-2020)
• 8.2 Biopharmaceutical Third Party Logistics Key Players in China (2019-2020)
• 8.3 China Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
• 8.4 China Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Biopharmaceutical Third Party Logistics Market Size (2015-2020)
• 9.2 Biopharmaceutical Third Party Logistics Key Players in Japan (2019-2020)
• 9.3 Japan Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
• 9.4 Japan Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Biopharmaceutical Third Party Logistics Market Size (2015-2020)
• 10.2 Biopharmaceutical Third Party Logistics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

11 India

• 11.1 India Biopharmaceutical Third Party Logistics Market Size (2015-2020)
• 11.2 Biopharmaceutical Third Party Logistics Key Players in India (2019-2020)
• 11.3 India Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
• 11.4 India Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Biopharmaceutical Third Party Logistics Market Size (2015-2020)
• 12.2 Biopharmaceutical Third Party Logistics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Biopharmaceutical Third Party Logistics Market Size by Type (2015-2020)
• 12.4 Central & South America Biopharmaceutical Third Party Logistics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 DHL
  • 13.1.1 DHL Company Details
  • 13.1.2 DHL Business Overview and Its Total Revenue
  • 13.1.3 DHL Biopharmaceutical Third Party Logistics Introduction
  • 13.1.4 DHL Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020))
  • 13.1.5 DHL Recent Development
• 13.2 Kuehne + Nagel
  • 13.2.1 Kuehne + Nagel Company Details
  • 13.2.2 Kuehne + Nagel Business Overview and Its Total Revenue
  • 13.2.3 Kuehne + Nagel Biopharmaceutical Third Party Logistics Introduction
  • 13.2.4 Kuehne + Nagel Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 13.2.5 Kuehne + Nagel Recent Development
• 13.3 DB Schenker Logistics
  • 13.3.1 DB Schenker Logistics Company Details
  • 13.3.2 DB Schenker Logistics Business Overview and Its Total Revenue
  • 13.3.3 DB Schenker Logistics Biopharmaceutical Third Party Logistics Introduction
  • 13.3.4 DB Schenker Logistics Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 13.3.5 DB Schenker Logistics Recent Development
• 13.4 Nippon Express
  • 13.4.1 Nippon Express Company Details
  • 13.4.2 Nippon Express Business Overview and Its Total Revenue
  • 13.4.3 Nippon Express Biopharmaceutical Third Party Logistics Introduction
  • 13.4.4 Nippon Express Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 13.4.5 Nippon Express Recent Development
• 13.5 C.H. Robinson Worldwide
  • 13.5.1 C.H. Robinson Worldwide Company Details
  • 13.5.2 C.H. Robinson Worldwide Business Overview and Its Total Revenue
  • 13.5.3 C.H. Robinson Worldwide Biopharmaceutical Third Party Logistics Introduction
  • 13.5.4 C.H. Robinson Worldwide Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 13.5.5 C.H. Robinson Worldwide Recent Development
• 13.6 UPS Supply Chain Solutions
  • 13.6.1 UPS Supply Chain Solutions Company Details
  • 13.6.2 UPS Supply Chain Solutions Business Overview and Its Total Revenue
  • 13.6.3 UPS Supply Chain Solutions Biopharmaceutical Third Party Logistics Introduction
  • 13.6.4 UPS Supply Chain Solutions Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 13.6.5 UPS Supply Chain Solutions Recent Development
• 13.7 DSV
  • 13.7.1 DSV Company Details
  • 13.7.2 DSV Business Overview and Its Total Revenue
  • 13.7.3 DSV Biopharmaceutical Third Party Logistics Introduction
  • 13.7.4 DSV Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 13.7.5 DSV Recent Development
• 13.8 Sinotrans
  • 13.8.1 Sinotrans Company Details
  • 13.8.2 Sinotrans Business Overview and Its Total Revenue
  • 13.8.3 Sinotrans Biopharmaceutical Third Party Logistics Introduction
  • 13.8.4 Sinotrans Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 13.8.5 Sinotrans Recent Development
• 13.9 CEVA Logistics
  • 13.9.1 CEVA Logistics Company Details
  • 13.9.2 CEVA Logistics Business Overview and Its Total Revenue
  • 13.9.3 CEVA Logistics Biopharmaceutical Third Party Logistics Introduction
  • 13.9.4 CEVA Logistics Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 13.9.5 CEVA Logistics Recent Development
• 13.10 Expeditors International of Washington
  • 13.10.1 Expeditors International of Washington Company Details
  • 13.10.2 Expeditors International of Washington Business Overview and Its Total Revenue
  • 13.10.3 Expeditors International of Washington Biopharmaceutical Third Party Logistics Introduction
  • 13.10.4 Expeditors International of Washington Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 13.10.5 Expeditors International of Washington Recent Development
• 13.11 Dachser
  • 10.11.1 Dachser Company Details
  • 10.11.2 Dachser Business Overview and Its Total Revenue
  • 10.11.3 Dachser Biopharmaceutical Third Party Logistics Introduction
  • 10.11.4 Dachser Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 10.11.5 Dachser Recent Development
• 13.12 Panalpina
  • 10.12.1 Panalpina Company Details
  • 10.12.2 Panalpina Business Overview and Its Total Revenue
  • 10.12.3 Panalpina Biopharmaceutical Third Party Logistics Introduction
  • 10.12.4 Panalpina Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 10.12.5 Panalpina Recent Development
• 13.13 GEODIS
  • 10.13.1 GEODIS Company Details
  • 10.13.2 GEODIS Business Overview and Its Total Revenue
  • 10.13.3 GEODIS Biopharmaceutical Third Party Logistics Introduction
  • 10.13.4 GEODIS Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 10.13.5 GEODIS Recent Development
• 13.14 Toll Holdings
  • 10.14.1 Toll Holdings Company Details
  • 10.14.2 Toll Holdings Business Overview and Its Total Revenue
  • 10.14.3 Toll Holdings Biopharmaceutical Third Party Logistics Introduction
  • 10.14.4 Toll Holdings Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 10.14.5 Toll Holdings Recent Development
• 13.15 J.B. Hunt (JBI, DCS & ICS)
  • 10.15.1 J.B. Hunt (JBI, DCS & ICS) Company Details
  • 10.15.2 J.B. Hunt (JBI, DCS & ICS) Business Overview and Its Total Revenue
  • 10.15.3 J.B. Hunt (JBI, DCS & ICS) Biopharmaceutical Third Party Logistics Introduction
  • 10.15.4 J.B. Hunt (JBI, DCS & ICS) Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 10.15.5 J.B. Hunt (JBI, DCS & ICS) Recent Development
• 13.16 Hitachi Transport System
  • 10.16.1 Hitachi Transport System Company Details
  • 10.16.2 Hitachi Transport System Business Overview and Its Total Revenue
  • 10.16.3 Hitachi Transport System Biopharmaceutical Third Party Logistics Introduction
  • 10.16.4 Hitachi Transport System Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 10.16.5 Hitachi Transport System Recent Development
• 13.17 XPO Logistics
  • 10.17.1 XPO Logistics Company Details
  • 10.17.2 XPO Logistics Business Overview and Its Total Revenue
  • 10.17.3 XPO Logistics Biopharmaceutical Third Party Logistics Introduction
  • 10.17.4 XPO Logistics Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 10.17.5 XPO Logistics Recent Development
• 13.18 GEFCO
  • 10.18.1 GEFCO Company Details
  • 10.18.2 GEFCO Business Overview and Its Total Revenue
  • 10.18.3 GEFCO Biopharmaceutical Third Party Logistics Introduction
  • 10.18.4 GEFCO Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 10.18.5 GEFCO Recent Development
• 13.19 Yusen Logistics
  • 10.19.1 Yusen Logistics Company Details
  • 10.19.2 Yusen Logistics Business Overview and Its Total Revenue
  • 10.19.3 Yusen Logistics Biopharmaceutical Third Party Logistics Introduction
  • 10.19.4 Yusen Logistics Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 10.19.5 Yusen Logistics Recent Development
• 13.20 Agility
  • 10.20.1 Agility Company Details
  • 10.20.2 Agility Business Overview and Its Total Revenue
  • 10.20.3 Agility Biopharmaceutical Third Party Logistics Introduction
  • 10.20.4 Agility Revenue in Biopharmaceutical Third Party Logistics Business (2015-2020)
  • 10.20.5 Agility Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer